| 摘要 |
Use of a solution consisting of epinastine as an active substance, optionally in the form of its racemate, the enantiomers, and optionally in the form of the pharmacologically acceptable acid addition salts thereof in a concentration of 0.0005 to 0.1 wt. %; water or a physiological saline solution as solvent; a buffer for adjusting the pH to a value from 6.5 to 7.2, optionally by the addition of sodium hydroxide; a preservative and optionally chelating agents; viscosity agents; penetration promoters, antioxidants and/or physiologically acceptable agents for adjusting the tonicity of the solution, for preparing a medicament for topical application to the conjunctiva or nasal mucosa for treating late phase reaction in allergic rhinitis or conjunctivitis. |
